| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Changik Jo | |
| P2860 | cites work | A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care | Q46123710 |
| Attention-deficit/hyperactivity disorder: increased costs for patients and their families | Q47375206 | ||
| The economic burden of anxiety disorders in the 1990s. | Q50650940 | ||
| Medical care expenditures for diabetes, its chronic complications, and its comorbidities. | Q52205274 | ||
| Use and misuse of population attributable fractions. | Q52243539 | ||
| Department of Epidemiology and Public Health, School of Medicine, Yale University, New Haven, CT. | Q52764460 | ||
| The friction cost method for measuring indirect costs of disease. | Q53643490 | ||
| The friction cost method: A comment | Q57345719 | ||
| Cost-of-illness methodology: a guide to current practices and procedures | Q71960493 | ||
| Cost-of-illness studies: a major headache? | Q74823054 | ||
| The state of the art of cost-of-illness estimates | Q77536592 | ||
| National Medical Spending Attributable To Overweight And Obesity: How Much, And Who's Paying? | Q22241403 | ||
| Productivity-cost controversies in cost-effectiveness analysis: review and research agenda | Q33544596 | ||
| Costs of illness in cost-effectiveness analysis. A review of the methodology | Q33568955 | ||
| Costs of diabetes. A methodological analysis of the literature. | Q33761574 | ||
| Perspectives in economic evaluation | Q33790200 | ||
| Willingness to pay for a quality-adjusted life year: in search of a standard | Q33993542 | ||
| Usefulness of US cost-of-illness studies in healthcare decision making | Q34205987 | ||
| A review of adjusted estimators of attributable risk | Q34304066 | ||
| Cost of illness studies: what is good about them? | Q35389768 | ||
| The economic burden of coronary heart disease in the UK. | Q35580657 | ||
| Economics and obesity: costing the problem or evaluating solutions? | Q35674451 | ||
| Cost-of-illness analysis. What room in health economics? | Q36247993 | ||
| Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. | Q37072944 | ||
| Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. | Q40433916 | ||
| Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers | Q40518259 | ||
| The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia | Q40807504 | ||
| Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation | Q40821730 | ||
| A review of cost-of-illness studies on obesity. | Q40843177 | ||
| Methods of calculating deaths attributable to obesity | Q43496490 | ||
| Two methods of estimating health costs linked to alcoholism in France (with a note on social costs). | Q43515664 | ||
| A national study of medical care expenditures for respiratory conditions | Q44294530 | ||
| Economic costs of diabetes in the US in 2002. | Q44892463 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| cost of illness | Q66969671 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 327-337 | |
| P577 | publication date | 2014-12-01 | |
| 2014-12-24 | |||
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Cost-of-illness studies: concepts, scopes, and methods | |
| P478 | volume | 20 |
| Q94410474 | A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study |
| Q38600977 | A Systematic Review of Cost-of-Illness Studies of Multimorbidity. |
| Q89668860 | Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence |
| Q49605864 | Air Pollution, Disease Burden, and Health Economic Loss in China |
| Q57143941 | An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies |
| Q92188732 | Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania |
| Q47560928 | Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action |
| Q38848894 | Burden of Wet Age-Related Macular Degeneration and Its Economic Implications in Singapore in the Year 2030. |
| Q89950406 | Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study |
| Q64226909 | Burden of non-communicable diseases in Iraq after the 2003 war |
| Q26774170 | Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples |
| Q91792709 | Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors |
| Q92060542 | Cost of Hypertension Illness and Associated Factors Among Patients Attending Hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia |
| Q48225587 | Cost of asthma in children: A nationwide, population-based, cost-of-illness study. |
| Q47729439 | Cost of diabetes mellitus in Africa: a systematic review of existing literature. |
| Q37326323 | Cost of illness for outpatients attending public and private hospitals in Bangladesh |
| Q98293272 | Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study |
| Q60954523 | Cost of oropharyngeal dysphagia after stroke: protocol for a systematic review |
| Q60046568 | Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review |
| Q47578242 | Cost-effectiveness of dengue vaccination in ten endemic countries |
| Q47353417 | Cost-of-Illness in Rare Diseases. |
| Q41975750 | Cost-of-illness of cholera to households and health facilities in rural Malawi. |
| Q89287946 | Costs of Invasive Meningococcal Disease: A Global Systematic Review |
| Q90636617 | Economic Burden of Malaria and Associated Factors Among Rural Households in Chewaka District, Western Ethiopia |
| Q30234748 | Economic Burden of Obesity: A Systematic Literature Review |
| Q30244295 | Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies |
| Q92331579 | Economic burden of Huntington's disease in Peru |
| Q58794504 | Economic burden of caregiving for persons with severe mental illness in sub-Saharan Africa: A systematic review |
| Q61798363 | Economic burden of dengue in Indonesia |
| Q89997982 | Economic burden of migraine in Latvia and Lithuania: direct and indirect costs |
| Q92001620 | Economic burden of multiple sclerosis on Kuwait health care system |
| Q92809188 | Economic burden of slow learners: A prevalence-based cost of illness study of its direct, indirect, and intangible costs |
| Q92556115 | Economic burden of specific learning disability: A prevalence-based cost of illness study of its direct, indirect, and intangible costs |
| Q58756508 | Economic burden of the therapeutic management of mental illnesses and its effect on household purchasing power |
| Q90622699 | Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program |
| Q53703124 | Estimating the burden of rabies in Ethiopia by tracing dog bite victims. |
| Q55073647 | Evaluating Health Co-Benefits of Climate Change Mitigation in Urban Mobility. |
| Q31125979 | Health Economic Data in Reimbursement of New Medical Technologies: Importance of the Socio-Economic Burden as a Decision-Making Criterion |
| Q104567545 | Health and economic impact of air pollution in the states of India: the Global Burden of Disease Study 2019 |
| Q36228380 | Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland |
| Q56525413 | Health-related costs in a sample of premenopausal non-diabetic overweight or obese females in Antwerp region: a cost-of-illness analysis |
| Q38629751 | Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data. |
| Q92675069 | Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden |
| Q42362029 | Household costs and time to seek care for pregnancy related complications: The role of results-based financing |
| Q64318907 | How Cost-of-Illness (COI) Study Provides Direct and Indirect Costs of Multiple Sclerosis (MS) in Bosnia and Herzegovina ? |
| Q92703340 | Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review |
| Q90596433 | Lifetime costs of invasive meningococcal disease: A Markov model approach |
| Q91789007 | Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia |
| Q89834871 | Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers |
| Q57472303 | Parental costs for in-patient neonatal services for perinatal asphyxia and low birth weight in Ghana |
| Q64075162 | Postoperative Atrial Fibrillation: Evaluation of its Economic Impact on the Costs of Cardiac Surgery |
| Q90739764 | Preterm birth and economic benefits of reduced maternal exposure to fine particulate matter |
| Q90224486 | Production Losses Associated with Alcohol-Attributable Mortality in the European Union |
| Q99579109 | Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data |
| Q37640499 | Productivity costs and years of potential life lost associated with five leading causes of death: Evidence from Iran (2006-2010). |
| Q27010597 | Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies |
| Q47552620 | Resource utilisation and costs in predementia and dementia: a systematic review protocol |
| Q58729755 | Social economic costs of COPD in Extremadura (Spain): an observational study |
| Q33710335 | Societal costs of fetal alcohol syndrome in Sweden |
| Q37710224 | Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson's Disease |
| Q90304858 | Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kem |
| Q58588372 | Temporal changes in diet quality and the associated economic burden in Canada |
| Q90410056 | The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018 |
| Q57146464 | The Estimates of the Health and Economic Burden of Dengue in Vietnam |
| Q91549196 | The Factors Associated With Direct Medical Costs in Gastric Cancer Patients: Quantile Regression Approach Compared With Gamma Regression |
| Q93002276 | The Impact of Dengue on Economic Growth: The Case of Southern Taiwan |
| Q46409106 | The Lancet Commission on pollution and health |
| Q64107348 | The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California |
| Q54969920 | The burden of acute respiratory infections in Ecuador 2011-2015. |
| Q61448971 | The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni |
| Q98512958 | The cost of mental disorders: a systematic review |
| Q90468867 | The economic burden of cancers attributable to smoking in Korea, 2014 |
| Q57921948 | The economic burden of oral cancer in Iran |
| Q47334574 | The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). |
| Q64072486 | Treatment cost and costing model of obstetric complications at a hospital in Myanmar |
| Q41632919 | Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study. |
| Q36343894 | Use of medical services and medicines attributable to type 2 diabetes care in Yaoundé, Cameroon: a cross-sectional study |
| Q77791164 | Workplace indirect cost impacts of nasal and sinus symptoms and related conditions |
Search more.